These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24141459)

  • 1. Lithium ameliorates open-field and elevated plus maze behaviors, and brain phospho-glycogen synthase kinase 3-beta expression in fragile X syndrome model mice.
    Chen X; Sun W; Pan Y; Yang Q; Cao K; Zhang J; Zhang Y; Chen M; Chen F; Huang Y; Dai L; Chen S
    Neurosciences (Riyadh); 2013 Oct; 18(4):356-62. PubMed ID: 24141459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.
    Yuskaitis CJ; Mines MA; King MK; Sweatt JD; Miller CA; Jope RS
    Biochem Pharmacol; 2010 Feb; 79(4):632-46. PubMed ID: 19799873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
    Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS
    PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LiCl Pretreatment Ameliorates Adolescent Methamphetamine Exposure-Induced Long-Term Alterations in Behavior and Hippocampal Ultrastructure in Adulthood in Mice.
    Yan P; Xu D; Ji Y; Yin F; Cui J; Su R; Wang Y; Zhu Y; Wei S; Lai J
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):303-316. PubMed ID: 30649326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.
    Sade Y; Toker L; Kara NZ; Einat H; Rapoport S; Moechars D; Berry GT; Bersudsky Y; Agam G
    Transl Psychiatry; 2016 Dec; 6(12):e968. PubMed ID: 27922641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
    Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
    J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
    Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK
    Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
    Li X; Friedman AB; Zhu W; Wang L; Boswell S; May RS; Davis LL; Jope RS
    Biol Psychiatry; 2007 Jan; 61(2):216-22. PubMed ID: 16806104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscarnet, an inhibitor of the sodium-phosphate cotransporter NaPi-IIa, inhibits phosphorylation of glycogen synthase kinase-3β by lithium in the rat kidney cortex.
    Uwai Y; Kawasaki T; Nabekura T
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):256-9. PubMed ID: 27238574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.
    O'Brien WT; Harper AD; Jové F; Woodgett JR; Maretto S; Piccolo S; Klein PS
    J Neurosci; 2004 Jul; 24(30):6791-8. PubMed ID: 15282284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
    Liu ZH; Chuang DM; Smith CB
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):618-30. PubMed ID: 20497624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
    Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
    Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
    Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.
    Guo W; Murthy AC; Zhang L; Johnson EB; Schaller EG; Allan AM; Zhao X
    Hum Mol Genet; 2012 Feb; 21(3):681-91. PubMed ID: 22048960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A beta-arrestin 2 signaling complex mediates lithium action on behavior.
    Beaulieu JM; Marion S; Rodriguiz RM; Medvedev IO; Sotnikova TD; Ghisi V; Wetsel WC; Lefkowitz RJ; Gainetdinov RR; Caron MG
    Cell; 2008 Jan; 132(1):125-36. PubMed ID: 18191226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
    Urs NM; Snyder JC; Jacobsen JP; Peterson SM; Caron MG
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20732-7. PubMed ID: 23188793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout mice in understanding the mechanism of action of lithium.
    Agam G; Bersudsky Y; Berry GT; Moechars D; Lavi-Avnon Y; Belmaker RH
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1121-5. PubMed ID: 19754464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anxiogenic and anxiolytic effects of lithium chloride under preventive and therapeutic treatments of male mice with repeated experience of aggression].
    Smagin DA; Kudryavtseva NN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(6):646-59. PubMed ID: 25975141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.